Back
Aurinia Pharmaceuticals Stock Price Chart
How to Turn the AI Energy Crisis into BIG Profits
And investors who move now into one technology could make a whole lot of money.
Buy
56
AUPH
Aurinia Pharmaceuticals
Last Price:
$9.04
Seasonality Move:
22.59%
7 Day Trial
ALL ACCESS PASS
$
7
The AI Energy Miracle
Details Here.-
The current trend is moderately bearish and AUPH is experiencing slight selling pressure.
Aurinia Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.44 | Sell |
| 20-day SMA: | 9.18 | Sell |
| 50-day SMA: | 8.24 | Buy |
| 200-day SMA: | 6.37 | Buy |
| 8-day EMA: | 9.27 | Sell |
| 20-day EMA: | 9.09 | Sell |
| 50-day EMA: | 8.42 | Buy |
| 200-day EMA: | 7.26 | Buy |
Aurinia Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 51.75 | Buy |
| Chaikin Money Flow: | -459691 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.42 - 9.56) | Buy |
| Bollinger Bands (100): | (6.26 - 8.56) | Buy |
Aurinia Pharmaceuticals Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aurinia Pharmaceuticals Stock
Is Aurinia Pharmaceuticals Stock a Buy?
-
Aurinia Pharmaceuticals share price is 9.03 while AUPH 8-day simple moving average is 9.44, which is a Sell signal.
-
The stock price of AUPH is 9.03 while Aurinia Pharmaceuticals 20-day SMA is 9.18, which makes it a Sell.
-
Aurinia Pharmaceuticals 50-day simple moving average is 8.24 while AUPH share price is 9.03, making it a Buy technically.
-
AUPH stock price is 9.03 and Aurinia Pharmaceuticals 200-day simple moving average is 6.37, creating a Buy signal.
AUPH Technical Analysis vs Fundamental Analysis
Buy
56
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy or a Sell?
-
Aurinia Pharmaceuticals stock is rated a BuyThe current Aurinia Pharmaceuticals [AUPH] share price is $9.03. The Score for AUPH is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Aurinia Pharmaceuticals Stock Info
Market Cap:
1.3B
Price in USD:
9.03
Share Volume:
1.6M
Aurinia Pharmaceuticals 52-Week Range
52-Week High:
10.67
52-Week Low:
4.71
Buy
56
Aurinia Pharmaceuticals (AUPH)
is a Buy
Aurinia Pharmaceuticals Share Price Forecast
-
What is the Aurinia Pharmaceuticals stock price today?The Aurinia Pharmaceuticals stock price is 9.03 USD today.
-
Will AUPH stock go up or go down?Aurinia Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Aurinia Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aurinia Pharmaceuticals is not overvalued.
Is Aurinia Pharmaceuticals Stock a Buy?
-
Aurinia Pharmaceuticals share price is 9.03 while AUPH 8-day exponential moving average is 9.27, which is a Sell signal.
-
The stock price of AUPH is 9.03 while Aurinia Pharmaceuticals 20-day EMA is 9.09, which makes it a Sell.
-
Aurinia Pharmaceuticals 50-day exponential moving average is 8.42 while AUPH share price is 9.03, making it a Buy technically.
-
AUPH stock price is 9.03 and Aurinia Pharmaceuticals 200-day simple moving average is 7.26, creating a Buy signal.
Fundamental Analysis of Aurinia Pharmaceuticals
Is Aurinia Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.
Technical Analysis of Aurinia Pharmaceuticals
Should I short Aurinia Pharmaceuticals stock?
-
AUPH Moving Average Covergence Divergence (MACD) indicator is 0.3, suggesting Aurinia Pharmaceuticals is a Buy
-
Aurinia Pharmaceuticals Relative Strength Index (RSI) is 51.75, which suggest Aurinia Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Aurinia Pharmaceuticals is (8.42 - 9.56), which suggest Aurinia Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Aurinia Pharmaceuticals is (6.26 - 8.56), which suggest Aurinia Pharmaceuticals is a Buy
* Aurinia Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.